Selectis Health, Inc. (GBCS) Stock Price & Analysis
Selectis Health, Inc. (GBCS) rose 0.53% to USD 5.74 as of September 8, 2026 at 21:55 UTC, according to Nexqual real-time market data.
GBCS last closed at USD 5.71; the session ranged USD 5.74–5.74 on volume of 800 shares. Market capitalization is $17.60M, with a 52-week range of USD 1.5–5.74 (OQB). Source: Nexqual, September 8, 2026 at 21:55 UTC.
Key Statistics (as of September 8, 2026 at 21:55 UTC)
| Price | USD 5.74 |
|---|---|
| Change | ▲ 0.53% (up) |
| Previous Close | USD 5.71 |
| Open | USD 5.74 |
| Day Range | USD 5.74 – 5.74 |
| 52-Week Range | USD 1.5 – 5.74 |
| Volume | 800 shares |
| Market Cap | $17.60M |
| Exchange | OQB |
Technical Analysis (GBCS)
Nexqual's technical model rates GBCS "BUY" based on 5 bullish and 1 bearish signals across 126 daily candles, as of September 8, 2026 at 21:55 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 67.25 (neutral) |
| vs SMA50 | Above (USD 5.43) |
| MACD | 0.1 (positive) |
Analyst Ratings (GBCS)
Wall Street analysts rate GBCS "None", per Nexqual as of September 8, 2026 at 21:55 UTC.
| Consensus Rating | None |
|---|
Earnings (GBCS)
Source: Nexqual, September 8, 2026 at 21:55 UTC.
Financials & Fundamentals (GBCS)
| Total Revenue | $32.53M |
|---|---|
| Revenue Growth (YoY) | -54.70% |
| Gross Margin | +20.92% |
| Operating Margin | -44.45% |
| Profit Margin | +44.88% |
| ROE | +1852.01% |
| Debt / Equity | 213.2 |
| Current Ratio | 0.84 |
| Total Cash | $7.73M |
| Total Debt | $17.00M |
| Free Cash Flow | $-3.05M |
Source: Nexqual, September 8, 2026 at 21:55 UTC.
Financial Health Score (GBCS)
Nexqual rates Selectis Health, Inc.'s overall financial health "Weak" across five dimensions, as of September 8, 2026 at 21:55 UTC.
| Growth | Critical — Revenue -55% YoY (latest Q), sharp decline |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Critical — $8M cash vs $17M debt |
| Cash Flow | Weak — FCF negative: -$3M, burning cash |
| Efficiency | Strong — ROE 1852%, ROA -7.8% |
Ownership (GBCS)
| Insider Ownership | +22.15% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 3.07M |
| Float | 2.39M |
Source: Nexqual, September 8, 2026 at 21:55 UTC.
Leadership (GBCS)
Selectis Health, Inc. is led by Krystal Eckhart (age 40), Interim CEO & CFO and VP of Revenue Management, per Nexqual as of September 8, 2026 at 21:55 UTC.
| Interim CEO & CFO and VP of Revenue Management | Krystal Eckhart (age 40) |
|---|---|
| Vice President of Operations | Sarah Day |
| Director & Legal Counsel | Clifford L. Neuman (age 77) |
From Selectis Health, Inc.'s Latest SEC 10-K Filing (filed 2026-04-15)
Key Strengths & Strategy (as disclosed to the SEC)
- Selectis Health, Inc. is a healthcare owner-operator that acquires, develops, and manages skilled nursing facilities, assisted living facilities, and independent living facilities across the South and Southeastern United States.
- The Company currently operates eight properties in Arkansas and Oklahoma, providing post-acute and skilled nursing care, assisted and independent living services, and continuing care retirement programs, with reimbursement sourced through Medicare, Medicaid, and private pay arrangements.
- Selectis is focused on delivering quality resident care while pursuing strategic growth opportunities in an expanding senior healthcare market.
- Selectis Health, Inc. was established and incorporated on June 08, 1978, in Utah.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| TBTC | Table Trac, Inc. | USD 5.99 | ▲ 0.5% |
| BTVRF | BLUERUSH INC. | USD 0 | ▲ 0% |
| XTMIF | XTM Inc. | USD 0 | ▲ 0% |
| EFRMF | EAST AFRICA METALS INC | USD 0.05 | ▲ 0% |
| RENO | Renovare Environmental, Inc. | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 21:55 UTC. This page is informational and not investment advice.